Genetic/familial high-risk assessment: breast and ovarian, version 1.2014
- PMID: 25190698
- DOI: 10.6004/jnccn.2014.0127
Genetic/familial high-risk assessment: breast and ovarian, version 1.2014
Abstract
During the past few years, several genetic aberrations that may contribute to increased risks for development of breast and/or ovarian cancers have been identified. The NCCN Guidelines for Genetic/Familial High-Risk Assessment: Breast and Ovarian focus specifically on the assessment of genetic mutations in BRCA1/BRCA2, TP53, and PTEN, and recommend approaches to genetic testing/counseling and management strategies in individuals with these mutations. This portion of the NCCN Guidelines includes recommendations regarding diagnostic criteria and management of patients with Cowden Syndrome/PTEN hamartoma tumor syndrome.
Copyright © 2014 by the National Comprehensive Cancer Network.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous
